drugset / Trial / NCT02481518
Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to determine whether magnesium preloading reduce incident of cisplatin induced acute kidney injury in head and neck cancer who receiving low dose cisplatin (40 mg/m2 weekly for 7 weeks).
Timeline
- Start
- 2015-03
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 16 meq | Intravenous |
| Background | Potassium Chloride | Small molecule | 20 meq | Intravenous |